Clincosm LogoSign in Get a demo

Alzheimer's Disease

Showing NaN - NaN of 73
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alzheimer's Disease Trial in San Francisco, Minneapolis (levetiracetam)

Completed
Has Results
  • Alzheimer's Disease
  • San Francisco, California
  • +1 more
Apr 22, 2022

Alzheimer's Disease Trial in Worldwide (Aducanumab)

Active, not recruiting
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +296 more
May 12, 2022

A Study of Brain Aging in Vietnam War Veterans

Completed
  • Traumatic Brain Injury
  • +3 more
    • Sun City, Arizona
    • +18 more
    Nov 24, 2021

    Agitation, Alzheimer's Disease Trial in United States (AVP-923-20, Placebo, AVP-923-30)

    Completed
    Has Results
    • Agitation
    • Alzheimer's Disease
    • Phoenix, Arizona
    • +43 more
    Oct 29, 2021

    Alzheimer's Disease Trial in Worldwide (ABBV-8E12)

    Completed
    • Alzheimer's Disease
    • Phoenix, Arizona
    • +56 more
    Nov 15, 2021

    Alzheimer's Disease Trial in Worldwide (Aducanumab (BIIB037), Placebo)

    Terminated
    Has Results
    • Alzheimer's Disease
    • Aducanumab (BIIB037)
    • Placebo
    • Phoenix, Arizona
    • +180 more
    Aug 9, 2021

    Alzheimer's Disease Trial in Worldwide (Aducanumab (BIIB037), Placebo)

    Terminated
    Has Results
    • Alzheimer's Disease
    • Aducanumab (BIIB037)
    • Placebo
    • Birmingham, Alabama
    • +179 more
    Aug 9, 2021

    Alzheimer's Disease Trial in Worldwide (ABT-126)

    Terminated
    • Alzheimer's Disease
    • Long Beach, California
    • +38 more
    Jul 29, 2021

    Alzheimer's Disease Trial in Worldwide (Azeliragon, Placebo)

    Terminated
    Has Results
    • Alzheimer's Disease
    • Phoenix, Arizona
    • +114 more
    May 6, 2021

    Alzheimer's Disease Trial in Worldwide (LY3202626, Placebo)

    Terminated
    Has Results
    • Alzheimer's Disease
    • Irvine, California
    • +75 more
    Mar 22, 2021

    Alzheimer's Disease Trial in Worldwide (Atorvastatin)

    Completed
    • Alzheimer's Disease
    • Sun City, Arizona
    • +98 more
    Feb 17, 2021

    Alzheimer's Disease Trial in United States (Active Comparator: A, Placebo Comparator B, Active Comparator B)

    Completed
    • Alzheimer's Disease
    • Active Comparator: A
    • +3 more
    • Garden Grove, California
    • +7 more
    Nov 20, 2020

    Alzheimer's Disease Trial in United States (florbetapir F 18, Flortaucipir F18, Brain PET Scan)

    Completed
    Has Results
    • Alzheimer's Disease
    • florbetapir F 18
    • +2 more
    • Phoenix, Arizona
    • +26 more
    Sep 3, 2020

    Alzheimer's Disease Trial in Australia, United States (Flortaucipir F18, PET Scan)

    Completed
    Has Results
    • Alzheimer's Disease
    • Flortaucipir F18
    • PET Scan
    • Phoenix, Arizona
    • +30 more
    Sep 3, 2020

    Alzheimer's Disease Trial in United States (Aducanumab (recombinant, fully human anti-Aß IgG1 mAb), Placebo)

    Terminated
    • Alzheimer's Disease
    • Aducanumab (recombinant, fully human anti-Aβ IgG1 mAb)
    • Placebo
    • Tucson, Arizona
    • +31 more
    Jul 31, 2020

    Alzheimer's Disease Trial in Worldwide (Crenezumab, Placebo)

    Terminated
    Has Results
    • Alzheimer's Disease
    • Scottsdale, Arizona
    • +210 more
    Jul 1, 2020

    Alzheimer's Disease Trial in Worldwide (Crenezumab, Placebo)

    Terminated
    Has Results
    • Alzheimer's Disease
    • Phoenix, Arizona
    • +195 more
    Jul 1, 2020

    Alzheimer's Disease Trial in Worldwide (Crenezumab)

    Terminated
    Has Results
    • Alzheimer's Disease
    • Newport Beach, California
    • +65 more
    Jun 25, 2020

    Dementia, Alzheimer's Disease Trial in San Francisco (Preventing Loss of Independence through Exercise (PLIE), Usual Care)

    Completed
    Has Results
    • Dementia
    • Alzheimer's Disease
    • Preventing Loss of Independence through Exercise (PLIE)
    • Usual Care
    • San Francisco, California
      San Francisco VA Medical Center, San Francisco, CA
    Jun 4, 2020

    Alzheimer's Disease, Behavioral Variant Frontotemporal Dementia Trial in Worldwide (LMTM)

    Terminated
    Has Results
    • Alzheimer's Disease
    • Behavioral Variant Frontotemporal Dementia
    • Phoenix, Arizona
    • +134 more
    May 15, 2020

    Alzheimer's Disease Trial in San Francisco (TPI-287 2 mg/m2, TPI-287 6.3 mg/m2, TPI-287 20 mg/m2)

    Completed
    • Alzheimer's Disease
    • TPI-287 2 mg/m2
    • +3 more
    • San Francisco, California
      UCSF Memory and Aging Center
    Apr 13, 2020

    Alzheimer's Disease Trial in Worldwide (Crenezumab)

    Completed
    Has Results
    • Alzheimer's Disease
    • Phoenix, Arizona
    • +85 more
    Feb 18, 2020

    Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)

    Terminated
    Has Results
    • Alzheimer's Disease
    • Phoenix, Arizona
    • +192 more
    Sep 25, 2019

    Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)

    Terminated
    Has Results
    • Alzheimer's Disease
    • Phoenix, Arizona
    • +197 more
    Sep 25, 2019

    Alzheimer's Disease Trial in Worldwide (Solanezumab, Placebo)

    Terminated
    Has Results
    • Alzheimer's Disease
    • Phoenix, Arizona
    • +146 more
    Sep 25, 2019